Direct Implantation of Patient Brain Tumor Cells into Matching Locations in Mouse Brains for Patient-Derived Orthotopic Xenograft Model Development
Authors:
- Lin QiLQLin Qi
- Patricia BaxterPBPatricia Baxter
- Mari KogisoMKMari Kogiso
- Huiyuan ZhangHZHuiyuan Zhang
- Frank K. BraunFBFrank K. Braun
- Holly LindsayHLHolly Lindsay
- Sibo ZhaoSZSibo Zhao
- Sophie XiaoSXSophie Xiao
- Aalaa Sanad AbdallahAAAalaa Sanad Abdallah
- Milagros SuarezMSMilagros Suarez
- Zilu HuangZHZilu Huang
- Wan Yee TeoWTWan Yee Teo
Open Access
Abstract
Background: Despite multimodality therapies, the prognosis of patients with malignant brain tumors remains extremely poor. One of the major obstacles that hinders development of effective therapies is the limited availability of clinically relevant and biologically accurate (CRBA) mouse models. Methods: We have developed a freehand surgical technique that allows for rapid and safe injection of fresh human brain tumor specimens directly into the matching locations (cerebrum, cerebellum, or brainstem) in the brains of SCID mice. Results: Using this technique, we successfully developed 188 PDOX models from 408 brain tumor patient samples (both high-and low-grade) with a success rate of 72.3% in high-grade glioma, 64.2% in medulloblastoma, 50% in ATRT, 33.8% in ependymoma, and 11.6% in low-grade gliomas. Detailed characterization confirmed their replication of the histopathological and genetic abnormalities of the original patient tumors. Conclusions: The protocol is easy to follow, without a sterotactic frame, in order to generate large cohorts of tumor-bearing mice to meet the needs of biological studies and preclinical drug testing.Keywords
Funding Information
- NIH (RO1 CA185402, 1U01CA199288, UO1 1-U01-CA217613-01A1, 2UO1 CA199288-06, RP150032, RP-170169, CA100735, 2532341503)
- National Institutes of Health (RO1 CA185402, 1U01CA199288, UO1 1-U01-CA217613-01A1, 2UO1 CA199288-06, RP150032, RP-170169, CA100735, 2532341503)
- National Institutes of Health (RO1 CA185402, 1U01CA199288, UO1 1-U01-CA217613-01A1, 2UO1 CA199288-06, RP150032, RP-170169, CA100735, 2532341503)
- National Institutes of Health (RO1 CA185402, 1U01CA199288, UO1 1-U01-CA217613-01A1, 2UO1 CA199288-06, RP150032, RP-170169, CA100735, 2532341503)
- Cancer Prevention and Research Institute of Texas (RO1 CA185402, 1U01CA199288, UO1 1-U01-CA217613-01A1, 2UO1 CA199288-06, RP150032, RP-170169, CA100735, 2532341503)
- Cure Starts Now Foundation (RO1 CA185402, 1U01CA199288, UO1 1-U01-CA217613-01A1, 2UO1 CA199288-06, RP150032, RP-170169, CA100735, 2532341503)
- Golfers Against Cancer (RO1 CA185402, 1U01CA199288, UO1 1-U01-CA217613-01A1, 2UO1 CA199288-06, RP150032, RP-170169, CA100735, 2532341503)
- CDMRP DOD PRCRP (RO1 CA185402, 1U01CA199288, UO1 1-U01-CA217613-01A1, 2UO1 CA199288-06, RP150032, RP-170169, CA100735, 2532341503)
- Childhood Brain Tumor Foundation (RO1 CA185402, 1U01CA199288, UO1 1-U01-CA217613-01A1, 2UO1 CA199288-06, RP150032, RP-170169, CA100735, 2532341503)
- National Brain Tumor Foundation (RO1 CA185402, 1U01CA199288, UO1 1-U01-CA217613-01A1, 2UO1 CA199288-06, RP150032, RP-170169, CA100735, 2532341503)
- St. Baldrick’s Foundation (RO1 CA185402, 1U01CA199288, UO1 1-U01-CA217613-01A1, 2UO1 CA199288-06, RP150032, RP-170169, CA100735, 2532341503)
This publication has 58 references indexed in Scilit:
- Spatial Dissection of Invasive Front from Tumor Mass Enables Discovery of Novel microRNA Drivers of Glioblastoma InvasionAdvanced Science, 2021
- Orthotopic Patient-Derived Glioblastoma Xenografts in Mice2018
- Integrated analysis of pediatric glioblastoma reveals a subset of biologically favorable tumors with associated molecular prognostic markersActa Neuropathologica, 2015
- Match criteria for human cell line authentication: Where do we draw the line?International Journal of Cancer, 2012
- Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomasActa Neuropathologica, 2012
- Molecular subgroups of medulloblastoma: the current consensusActa Neuropathologica, 2011
- Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samplesActa Neuropathologica, 2011
- Neurosphere Formation Is an Independent Predictor of Clinical Outcome in Malignant GliomaStem Cells, 2009
- The culture of neural stem cellsJournal of Cellular Biochemistry, 2008
- In vitro characterization of a human neural progenitor cell coexpressing SSEA4 and CD133Journal of Neuroscience Research, 2006